Toxicity of Immunotherapies in Melanoma

April 22, 2015
Jeffrey S. Weber, MD, PhD

Special Reports, Melanoma (Issue 4), Volume 4, Issue 1

Jeffrey S. Weber, MD, PhD, a senior member at Moffitt Cancer Center, discusses toxicities associated with immunotherapies for the treatment of patients with melanoma.

Jeffrey S. Weber, MD, PhD, a senior member at Moffitt Cancer Center, discusses toxicities associated with immunotherapies for the treatment of patients with melanoma.

<<<

Back to the Melanoma Special Report